Literature DB >> 29425579

The impact of sleep disordered breathing on cardiovascular health in overweight children.

Rosemary S C Horne1, Genevieve Shandler2, Knarik Tamanyan2, Aidan Weichard2, Alexsandria Odoi2, Sarah N Biggs2, Margot J Davey3, Gillian M Nixon3, Lisa M Walter2.   

Abstract

BACKGROUND: Up to 50% of overweight/obese children have obstructive sleep apnea (OSA) compared to up to 6% of normal weight children. We compared cardiovascular variables between normal weight and overweight/obese children with and without OSA, and controls.
METHODS: Seventy-four referred children and 24 normal weight non-snoring controls (8-18 years) were recruited. Referred children were grouped according to their obstructive apnea hypopnea index (OAHI): OSA (>1 event/h) or primary snoring (PS ≤ 1 event/h) and whether they were normal weight (BMI z-score <1.04) or overweight/obese (BMI z-score ≥ 1.04). Wake blood pressure (BP), heart rate (HR), and pulse transit time (PTT, an inverse continuous surrogate measure of blood pressure) during sleep were recorded.
RESULTS: Wake BP was higher in the overweight/obese OSA group than in the control, normal weight PS, and overweight/obese PS groups (p < 0.05 for all). During sleep, BP, and HR were elevated in the overweight/obese OSA group compared to those in non-snoring controls (p < 0.05). More children who were overweight/obese had reduced BP and HR dipping from wake to sleep than normal weight children. The BMI z-score predicted HR and PTT when asleep and both age and BMI z-score predicted BP when awake.
CONCLUSION: This study showed that BMI has both combined and independent effects on BP and HR in children with OSA. We have previously shown that treatment of OSA reduces BP and suggest that treatment of OSA in the growing number of overweight/obese children may improve cardiovascular outcomes. Crown
Copyright © 2017. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood pressure; Heart rate; Heart rate variability; Nocturnal dipping; Pediatric; Sleep

Mesh:

Year:  2017        PMID: 29425579     DOI: 10.1016/j.sleep.2017.09.012

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  7 in total

Review 1.  OSA and Cardiovascular Risk in Pediatrics.

Authors:  David F Smith; Raouf S Amin
Journal:  Chest       Date:  2019-02-18       Impact factor: 9.410

2.  Overweight/Obese Status Synergistically Worsens Nocturnal Time-to-Time Blood Pressure in Children with Obstructive Sleep Apnea.

Authors:  Yunxiao Wu; Xuezhi Geng; Zhifei Xu; Xin Ni
Journal:  Nat Sci Sleep       Date:  2022-07-15

3.  Examining Associations Between Neighborhood-Level Social Vulnerability and Care for Children With Sleep-Disordered Breathing.

Authors:  Flora Yan; John L Pearce; Marvella E Ford; Paul J Nietert; Phayvanh P Pecha
Journal:  Otolaryngol Head Neck Surg       Date:  2022-03-08       Impact factor: 5.591

4.  Association Between Triglyceride Glucose Index-Waist Circumference and Risk of First Myocardial Infarction in Chinese Hypertensive Patients with Obstructive Sleep Apnoea: An Observational Cohort Study.

Authors:  Junli Hu; Xintian Cai; Nanfang Li; Qing Zhu; Wen Wen; Jing Hong; Delian Zhang; Xiaoguang Yao; Qin Luo; Le Sun
Journal:  Nat Sci Sleep       Date:  2022-05-19

5.  Racial and Ethnic Disparities in Utilization of Tonsillectomy among Medicaid-Insured Children.

Authors:  Phayvanh P Pecha; Marshall Chew; Anne L Andrews
Journal:  J Pediatr       Date:  2021-02-04       Impact factor: 6.314

6.  Reduction in Parasympathetic Tone During Sleep in Children With Habitual Snoring.

Authors:  Maria-Cecilia Lopes; Karen Spruyt; Leticia Azevedo-Soster; Agostinho Rosa; Christian Guilleminault
Journal:  Front Neurosci       Date:  2019-01-10       Impact factor: 4.677

7.  Heart rate variability spectrum characteristics in children with sleep apnea.

Authors:  Adrián Martín-Montero; Gonzalo C Gutiérrez-Tobal; Leila Kheirandish-Gozal; Jorge Jiménez-García; Daniel Álvarez; Félix Del Campo; David Gozal; Roberto Hornero
Journal:  Pediatr Res       Date:  2020-09-14       Impact factor: 3.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.